Tesamorelin may be described as a GHRH analog—but “GHRH analog” is not a complete molecular identity.
For professional research buyers, one structural detail matters immediately:
Tesamorelin is a modified 44-amino-acid GHRH analog with a characteristic N-terminal hexenoyl group.
That modification is part of the molecule.
So the important sourcing question is not simply:
“Is this a GHRH peptide?”
It is:
“Has the complete Tesamorelin molecule—including its defining structural modification—been verified?”
What Is Tesamorelin?
Tesamorelin, also known as TH9507 or TH-9507, is a synthetic analog of human growth hormone-releasing hormone.
Common identifiers include:
CAS: 218949-48-5
Molecular Formula: C221H366N72O67S
Molecular Weight: approximately 5135.9 g/mol
Tesamorelin contains the 44-amino-acid GHRH framework together with an N-terminal trans-3-hexenoyl modification.
This distinguishes Tesamorelin from simply supplying unmodified human GHRH.
Why the N-Terminal Modification Matters
Peptide identity is more than a familiar sequence name.
For Tesamorelin, the hexenoyl modification is an intentional structural feature associated with increased resistance to enzymatic degradation compared with native GHRH.
From an analytical perspective, this creates two separate identity questions:
Is the peptide backbone correct?
and
Is the expected N-terminal modification present?
A generic GHRH-like sequence without the intended modification should not automatically be described as fully verified Tesamorelin.
HPLC Purity Is Not the Same as Complete Identity
An HPLC purity percentage can describe chromatographic purity.
It does not independently prove every structural feature of the molecule.
For Tesamorelin, professional buyers may therefore consider:
- peptide identity;
- expected molecular mass;
- N-terminal modification;
- related peptide impurities;
- chromatographic purity;
- batch consistency.
This is why a useful quality chain is:
Sequence → Structural Modification → Molecular Identity → HPLC Purity → MS/LC-MS → Batch COA
Tesamorelin Is Also Not Generic GHRH
“GHRH peptide,” “Tesamorelin” and other GHRH analogs should not be used as interchangeable terms.
Different analogs may differ in:
- amino-acid sequence;
- terminal structure;
- chemical modification;
- stability;
- molecular mass;
- receptor pharmacology;
- analytical specification.
For reproducible laboratory research, the exact molecule matters.
Tesamorelin Research Material Is Not Automatically EGRIFTA
Tesamorelin is also the active molecule associated with regulated pharmaceutical products such as EGRIFTA.
However, this does not make every research-grade Tesamorelin material equivalent to the approved finished medicine.
A regulated finished pharmaceutical product has its own:
- formulation;
- manufacturing controls;
- excipients;
- potency specifications;
- sterility requirements;
- regulatory quality system;
- approved indication.
Sharing the same molecule name does not establish finished-product equivalence.
What Do Tesamorelin Reviews Say?
Online experiences are mixed.
Positive anecdotal discussions sometimes mention perceived:
- changes in visceral-fat measurements;
- body-composition changes;
- sleep;
- recovery;
- general well-being.
Negative or uncertain reports include:
- little or no noticeable effect;
- fluid retention;
- fatigue;
- joint or muscle discomfort;
- injection-site reactions;
- concern about cost or inconsistent outcomes.
These reports should be interpreted cautiously.
Online users frequently combine Tesamorelin with other research compounds, prescription products, dietary changes or exercise programs, making causality difficult to determine.
They also do not establish the identity, purity or quality of a specific research batch.
What Should a B2B Buyer Verify?
When evaluating a Tesamorelin supplier, professional research buyers may consider several questions.
Exact Molecular Identity
Does the analytical documentation support Tesamorelin rather than a generic GHRH-related peptide?
N-Terminal Modification
Does the specification correspond to the intended modified molecule?
HPLC Purity
What does the chromatographic result show for the actual production lot?
MS / LC-MS Identity
Where applicable, does mass analysis support the expected molecular species?
Related Substances
Are relevant peptide impurities appropriately specified?
Batch-Specific COA
Does the Certificate of Analysis correspond to the material actually supplied?
Lot Traceability
Can the vial, COA, specification and analytical records be connected to the same production lot?
Tesamorelin Research Peptide from Sunone
Sunone (Hong Kong) Biopharmaceutical International Technology Co., Limited supplies Tesamorelin / TH9507 for qualified laboratory research and biotechnology manufacturing applications.
Current listed specifications include:
Product: Tesamorelin
Synonyms: TH9507 / TH-9507
CAS: 218949-48-5
Molecular Formula: C221H366N72O67S
Molecular Weight: approximately 5135.9 g/mol
Product Type: Modified GHRH Analog
Grade: Research Grade
Purity Specification: ≥99% HPLC
Form: Lyophilized Powder
Storage: 2–8°C, protected from light
Documentation: Batch-specific COA, SDS and Specification Sheet available
Current listed B2B formats include:
5 mg × 10 vials
10 mg × 10 vials
Exact molecular identity, modification status, purity and analytical characteristics should always be reviewed against the applicable production-batch documentation.
Looking for a Tesamorelin supplier with B2B analytical documentation?
View Sunone Tesamorelin Specifications ：
Contact Sunone with your required quantity, packaging format, analytical-documentation requirements and OEM/ODM project specifications for a current quotation.
FAQ
Is Tesamorelin the same as natural GHRH?
No. Tesamorelin is a modified GHRH analog with a characteristic N-terminal structural modification.
What is TH9507?
TH9507 is a development name associated with Tesamorelin.
What is the CAS number of Tesamorelin?
Tesamorelin is commonly identified as CAS 218949-48-5.
Why does the N-terminal modification matter?
It is part of the intended Tesamorelin molecular structure and helps distinguish the molecule from unmodified GHRH.
Does ≥99% HPLC prove complete Tesamorelin identity?
No. Chromatographic purity and complete molecular identity are different analytical questions.
Is research-grade Tesamorelin equivalent to EGRIFTA?
No. An approved finished pharmaceutical product has product-specific formulation, manufacturing, quality and regulatory specifications that do not automatically apply to independently supplied research-grade material.
This content is provided for scientific and educational purposes only. SUNONE research peptide is for qualified labrtorynt, diagnois, druc tor mmatct or veteimant, use.research only, Not for human consumption, clinical treame. Purchasers are responsible for complying with applicable laws and regulations in their jurisdiction.
Leave a Reply